This inventor holds 3 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2024
Title: Innovations of Zachery Reichert in Epigenetic Research
Introduction
Zachery Reichert is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of epigenetics, particularly in the development of methods for reversing gene silencing. With a total of 3 patents to his name, Reichert's work is paving the way for advancements in disease treatment and prevention.
Latest Patents
One of Reichert's latest patents focuses on agents for reversing epigenetic silencing of genes. This invention provides methods for discovering agents that effectively reverse epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. The patent also outlines methods for reactivating silenced genes that have CpG island hypermethylation. Furthermore, it includes approaches for the treatment and prevention of diseases such as cancer and sickle cell anemia. By administering agents that modulate MBD protein-mediated transcriptional repression, the invention aims to increase gene transcription, thereby preventing or treating these diseases. Additionally, the compounds identified through this invention are useful for the treatment and prevention of various diseases.
Career Highlights
Zachery Reichert is affiliated with Johns Hopkins University, where he continues to engage in groundbreaking research. His work is characterized by a strong focus on the molecular mechanisms underlying gene regulation and the potential therapeutic applications of his findings.
Collaborations
Reichert collaborates with notable colleagues in his field, including William G Nelson and Srinivasan Yegnasubramanian. These collaborations enhance the depth and impact of his research, contributing to the advancement of knowledge in epigenetics.
Conclusion
Zachery Reichert's innovative work in epigenetics is making significant strides in the understanding and treatment of diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile